| Year |
Citation |
Score |
| 2024 |
Mack KN, Samuels ZV, Carter LM, Viray TD, Mandleywala K, Brooks CL, Hollingsworth MA, Radhakrishnan P, Lewis JS. Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 38485271 DOI: 10.2967/jnumed.123.266524 |
0.356 |
|
| 2024 |
Sarrett SM, Rodriguez C, Delaney S, Hosny MM, Sebastiano J, Santos-Coquillat A, Keinänen OM, Carter LM, Lastwika KJ, Lampe PD, Zeglis BM. Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung Cancer. Molecular Pharmaceutics. PMID 38331430 DOI: 10.1021/acs.molpharmaceut.3c01063 |
0.321 |
|
| 2023 |
Bauer D, Carter LM, Atmane MI, De Gregorio R, Michel A, Kaminsky S, Monette S, Li M, Schultz MK, Lewis JS. Pb-Pretargeted Theranostics for Pancreatic Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 37945380 DOI: 10.2967/jnumed.123.266388 |
0.327 |
|
| 2022 |
Tully KM, Tendler S, Carter LM, Sharma SK, Samuels ZV, Mandleywala K, Korsen JA, Delos Reyes AM, Piersigilli A, Travis WD, Sen T, Pillarsetty N, Poirier JT, Rudin CM, Lewis JS. Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer exhibits antitumor efficacy with low toxicity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35046060 DOI: 10.1158/1078-0432.CCR-21-1533 |
0.55 |
|
| 2021 |
Nie P, Kalidindi T, Nagle VL, Wu X, Li T, Liao GP, Frost G, Henry KE, Punzalan B, Carter LM, Lewis JS, Pillarsetty NVK, Li YM. Imaging of Cancer γ-Secretase Activity Using an Inhibitor-based PET Probe. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34475100 DOI: 10.1158/1078-0432.CCR-21-0940 |
0.319 |
|
| 2021 |
Pillarsetty N, Carter L, Lewis JS, Reiner T. REPLY TO LETTER TO THE EDITOR: POTENTIAL USE OF RADIOLABELED ANTIBODIES FOR IMAGING AND TREATMENT OF COVID-19. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 33893187 DOI: 10.2967/jnumed.121.261950 |
0.516 |
|
| 2021 |
Dacek MM, Veach DR, Cheal SM, Carter LM, McDevitt MR, Punzalan B, Burnes Vargas D, Kubik TZ, Monette S, Santich BH, Yang G, Ouerfelli O, Kesner AL, Cheung NV, Scheinberg DA, et al. Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications. Bioconjugate Chemistry. PMID 33819023 DOI: 10.1021/acs.bioconjchem.0c00595 |
0.304 |
|
| 2020 |
Mason CA, Carter LM, Mandleywala K, de Souza Franca PD, Meyer JP, Mamun T, Backer JM, Backer MV, Reiner T, Lewis JS. Imaging Early-Stage Metastases Using an F-Labeled VEGFR-1-Specific Single Chain VEGF Mutant. Molecular Imaging and Biology. PMID 33156495 DOI: 10.1007/s11307-020-01555-z |
0.611 |
|
| 2020 |
Pillarsetty N, Carter L, Lewis JS, Reiner T. Oncology-inspired treatment options for COVID-19. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32680924 DOI: 10.2967/Jnumed.120.249748 |
0.524 |
|
| 2020 |
Gonzales J, Pirovano G, Chow CY, de Souza Franca PD, Carter LM, Klint JK, Guru N, Lewis JS, King GF, Reiner T. Fluorescence labeling of a Na1.7-targeted peptide for near-infrared nerve visualization. Ejnmmi Research. 10: 49. PMID 32409881 DOI: 10.1186/S13550-020-00630-4 |
0.424 |
|
| 2020 |
Pirovano G, Jannetti SA, Carter LM, Sadique A, Kossatz S, Guru N, Demétrio De Souza França P, Maeda M, Zeglis BM, Lewis JS, Humm JL, Reiner T. Targeted brain tumor radiotherapy using an Auger emitter. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32066626 DOI: 10.1158/1078-0432.Ccr-19-2440 |
0.501 |
|
| 2019 |
Mason C, Kossatz S, Carter L, Pirovano G, Brand C, Guru N, Pérez-Medina C, Lewis JS, Mulder W, Reiner T. A Zr-HDL PET tracer monitors response to a CSF1R inhibitor. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31420495 DOI: 10.2967/Jnumed.119.230466 |
0.497 |
|
| 2019 |
Pereira PM, Mandleywala K, Ragupathi A, Carter LM, Goos JACM, Janjigian YY, Lewis JS. Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31171598 DOI: 10.2967/Jnumed.119.225813 |
0.317 |
|
| 2018 |
Pereira PMR, Sharma SK, Carter LM, Edwards KJ, Pourat J, Ragupathi A, Janjigian YY, Durack JC, Lewis JS. Caveolin-1 mediates cellular distribution of HER2 and affects trastuzumab binding and therapeutic efficacy. Nature Communications. 9: 5137. PMID 30510281 DOI: 10.1038/S41467-018-07608-W |
0.529 |
|
| 2018 |
Poty S, Carter LM, Mandleywala K, Membreno R, Abdel-Atti D, Ragupathi A, Scholz WW, Zeglis BM, Lewis JS. Leveraging bioorthogonal click chemistry to improve 225Ac-radioimmunotherapy of pancreatic ductal adenocarcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30352909 DOI: 10.1158/1078-0432.Ccr-18-1650 |
0.637 |
|
| 2018 |
Krebs S, Ahad A, Carter L, Eyquem J, Brand C, Bell M, Ponomarev V, Reiner T, Meares CF, Gottschalk S, Sadelain M, Larson SM, Weber WA. Antibody with infinite affinity for in vivo tracking of genetically engineered lymphocytes. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29903928 DOI: 10.2967/Jnumed.118.208041 |
0.545 |
|
| 2018 |
Jannetti SA, Carlucci G, Carney B, Kossatz S, Shenker L, Carter LM, Salinas B, Brand C, Sadique A, Donabedian PL, Cunanan KM, Gönen M, Ponomarev V, Zeglis BM, Souweidane MM, et al. PARP1-Targeted Radiotherapy in Mouse Models of Glioblastoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29572254 DOI: 10.2967/Jnumed.117.205054 |
0.528 |
|
| 2018 |
Carter LM, Poty S, Sharma SK, Lewis JS. Preclinical Optimization of Antibody-based Radiopharmaceuticals for Cancer Imaging and Radionuclide Therapy - Model, Vector, and Radionuclide Selection. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 29412489 DOI: 10.1002/Jlcr.3612 |
0.662 |
|
| Show low-probability matches. |